165 related articles for article (PubMed ID: 26597077)
1. Use of Single-Antigen Flow Beads Assays to Assess Anti-HLA Donor-Specific Antibody Strength.
Loiseau P; Amokhrane K; Visentin J; Kheav VD; Caillat-Zucman S; Taupin JL
Biol Blood Marrow Transplant; 2016 Feb; 22(2):394-395. PubMed ID: 26597077
[No Abstract] [Full Text] [Related]
2. Reply to: Use of Single-Antigen Flow Beads Assays to Assess Anti-HLA Donor-Specific Antibody Strength.
Cao K; Ciurea SO
Biol Blood Marrow Transplant; 2016 Feb; 22(2):395-396. PubMed ID: 26597078
[No Abstract] [Full Text] [Related]
3. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
5. Role of crossmatch testing when Luminex-SAB is negative in renal transplantation.
Jayant K; Reccia I; Julie BM; Sharma A; Halawa A
Pol Przegl Chir; 2018 Feb; 90(1):41-46. PubMed ID: 29513250
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
7. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients.
Fuggle SV; Martin S
Transplantation; 2008 Aug; 86(3):384-90. PubMed ID: 18698240
[TBL] [Abstract][Full Text] [Related]
8. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
[TBL] [Abstract][Full Text] [Related]
9. Lights and shadows of anti-HLA antibodies detected by solid-phase assay.
Picascia A; Sabia C; Grimaldi V; Montesano ML; Sommese L; Schiano C; Napoli C
Immunol Lett; 2014 Nov; 162(1 Pt A):181-7. PubMed ID: 25171913
[TBL] [Abstract][Full Text] [Related]
10. Successful engraftment of third allogeneic hematopoietic stem cell transplantation after two graft failures and treatment for anti-HLA antibody in a pediatric acquired aplastic anemia patient.
Zhu H; Luo C; He J; Ding L; Wang J; Luo C; Chen J
Pediatr Transplant; 2014 Dec; 18(8):896-8. PubMed ID: 25311402
[No Abstract] [Full Text] [Related]
11. HLA typing.
Hutchinson JA
Transplantation; 2015 Jan; 99(1):6-7. PubMed ID: 25525916
[No Abstract] [Full Text] [Related]
12. A new role for the virtual crossmatch in kidney allograft reuse.
Bryan CF; Abdulkarim B; Forster J; Nelson PW; Diederich D; Murillo D; Markham L
Transplantation; 2010 Mar; 89(6):764-5. PubMed ID: 20308864
[No Abstract] [Full Text] [Related]
13. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
14. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients.
Everly MJ
Clin Transpl; 2011; ():333-6. PubMed ID: 22755427
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
16. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
17. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
18. HLA match, mismatch and crossmatch: what clinicians should know?
Ghosh B; Pahari DK
J Indian Med Assoc; 2013 Aug; 111(8):524-8. PubMed ID: 24783390
[No Abstract] [Full Text] [Related]
19. Human leukocyte antigens and alloimmunization in heart transplantation: an open debate.
Picascia A; Grimaldi V; Casamassimi A; De Pascale MR; Schiano C; Napoli C
J Cardiovasc Transl Res; 2014 Oct; 7(7):664-75. PubMed ID: 25190542
[TBL] [Abstract][Full Text] [Related]
20. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]